Evidence · condition
Neuropathic pain
LAST REVIEWED 2026-09-22 · VERY LIMITED · NOT PROVEN
Ibogaine is not an established treatment for neuropathic pain. The public record includes a clinic-affiliated human case report, animal/congener pharmacology, and analog/review discussion — none of which upgrades the indication to proven.
Is ibogaine proven for neuropathic pain?
No — not established. Above-fold posture remains very limited / not proven. Book or podcast remyelination/pain anecdotes stay media-labeled until primary sources are cited.
- Evidence level
- Very limited — thinner than OUD observational literature
- Human clinical signal
- Case-report density, not confirmatory trials
- What is not shown
- Adequately powered controlled evidence that ibogaine treats neuropathic pain as a general indication
- Safety
- Cardiac / QT themes still apply — Safety / QTc
- Self-treatment
- Out of scope — DIY refusal
What exists (source-labeled)
Human case report (COI: Ambio-affiliated)
Dickinson et al., 2023. “Case report: Ibogaine reduced severe neuropathic pain associated with a case of brachial plexus nerve root avulsion.” Frontiers in Pain Research. PMID 37720911, DOI 10.3389/fpain.2023.1256396. Authors disclose affiliation/shareholding with Ambio Life Sciences (clinic offering ibogaine treatments) and funder involvement in design, analysis, and manuscript. Label: case report + COI / clinic-adjacent. Hypothesis-generating only.
Animal / congener pharmacology (not clinical proof)
Arias et al., 2020. Coronaridine congeners (including (±)-18-MC and (+)-catharanthine) decrease oxaliplatin-induced neuropathic pain behaviors in mice and inhibit α9α10 nAChRs / CaV2.2 pathways. Neuropharmacology. PMID 32540451, DOI 10.1016/j.neuropharm.2020.108194. Animal mechanism ≠ human efficacy.
Analog / review discussion
Tabernanthalog (TBG) reviews discuss non-hallucinogenic ibogaine analogs and cardiotoxicity mitigation themes (e.g., PMID 41898671, DOI 10.3390/ijms27062811). Relevant to analog R&D literacy — not proof that ibogaine treats neuropathic pain.
What does not exist (yet)
- Registered, adequately powered RCTs of ibogaine for neuropathic pain as a labeled indication.
- Independent replication of the brachial-plexus case outside clinic-funded authorship.
- Any basis for miracle remyelination / “pain cure” language in IbogaBase voice.
FAQ
Did a book or podcast prove remyelination / pain cure?
No. Media stays media-labeled. Miracle language is refused.
Does Ambio authorship invalidate the case report?
COI does not automatically equal fabrication; it does change how much weight a single case should carry. Readers should prefer independent replication.